For decades, surviving a heart attack has come with a lifelong prescription: Stay on medications called beta-blockers to help protect your heart. But doctors are taking a closer look at whether ...
The results run counter to ABYSS but align with other data showing beta-blockers shouldn’t continue indefinitely after MI.
The role of long-term beta-blocker therapy after a myocardial infarction in patients without left ventricular systolic dysfunction or heart failure is unclear in the era of contemporary ...
In stable patients without heart failure, discontinuing beta-blockers 1 year after a heart attack was noninferior to ...
Trial assessed outcomes of quitting therapy after 1 year among select MI survivors ...
Add Yahoo as a preferred source to see more of our stories on Google. A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood ...
In a recent study published in The New England Journal of Medicine, researchers conducted the Randomized Evaluation of Decreased Usage of Beta-Blockers after Acute Myocardial Infarction (REDUCE-AMI) ...
Please provide your email address to receive an email when new articles are posted on . Patients who received beta-blocker therapy reported higher anxiety, more frequent depressed mood and worse ...
Madrid, Spain – 30 August 2025: Beta-blocker therapy showed no evidence of an effect on all-cause death, reinfarction or heart failure admission in patients with myocardial infarction (MI) managed ...
Beta-blocker therapy after myocardial infarction (MI) failed to lower the rate of all-cause death, MI, or heart failure in patients with a left ventricular ejection fraction (LVEF) of at least 50%, ...
Madrid, Spain – 30 August 2025: Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality and major adverse cardiovascular events compared with no beta-blocker therapy in ...
A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood pressure, did not provide clear benefits for heart attack patients ...